Mr Max Elstein (Charing Cross Hospital Medical School, London) Pelvic Inflammation and the Intrauterine Contraceptive Device
We have been investigating intrauterine contraceptive devices in the Contraceptive Clinic at Charing Cross Hospital in Professor Norman Morris's department and have found an interesting trend in the incidence of pelvic inflammation (PID) when comparing the Lippes loop and the Birnberg bow (Table 1) . We are all aware of the difficulty of diagnosing pelvic inflammation in clinical practice and the reported incidence of cases of pelvic inflammation with IUDs varies considerably; it is exceedingly difficult to compare the findings of a number of clinicians in different populations. In this discussion Mr Mills and Mr Snaith have reported an exceedingly low incidence.
Our cases were all seen and followed up by me personally, some at Charing Cross where endometrial biopsies are taken and the others at a Family Planning Association clinic. The fact that endometrial biopsies are taken in the one series does not significantly alter the incidence of pelvic inflammation. The striking difference between the two types of devices remains evident (Table 1) . The diagnosis is made on clinical grounds. The symptoms are usually minimal such as backache, pelvic inflammation feeling off colour, dysmenorrhoea, often a premenstrual backache, pelvic discomfort and vaginal discharge. Many are silent. A few of these cases are very ill with high pyrexia and severe pain necessitating admission to hospital and may even present as pelvic peritonitis. On examination there is a variable degree of cervical excitation pain, there is always some degree of adnexal tenderness and in most cases there is a tender adnexal cystic mass. However, this can be very soft and easily missed. Investigations are not very helpful in confirming the diagnosis and in this series it is the exception rather than the rule that there is an increase in the sedimentation rate or a leucocytosis. One is left with the best test of all, the response to therapy: the majority of these cases respond to broad-spectrum antibiotic therapy sometimes reinforced with pelvic shortwave diathermy. This is a small series; however, in clinical gynecological practice I have also seen several cases of pelvic inflammation of varying degrees in women wearing an IUD with a cervical appendage or having had one previously removed. Some of these subacute cases were missed because practitioners were prepared to accept a certain degree of pelvic discomfort as part of the reaction of the uterus to an IUD. The point is that pelvic inflammation does occur in women with an IUD and there appears to be a significant predilection for those women using the Lippes loop, suggesting that organisms gain entry into the upper genital tract up the threads through the cervix. Bacteriological studies along these lines are in progress. In view of this and the possible damage that this pelvic inflammation may inflict on the tubes we feel that the IUD should not be used in women who are unaware of this risk and who would like to be sure of retaining their fertility.
Dr Charles HBirnberg (Brooklyn, NY, USA)
The insertion of an intrauterine contraceptive device is not an emergency procedure. I believe very strongly that no device should be inserted unless it is absolutely certain that the patient is not pregnant. Every patient should either have an immunological test for pregnancy or come back during her menstrual period, for the following reasons: (1) Assurance that she is not pregnant.
(2) The cervix is usually soft and dilated during her period, making the introduction simple. (3) The patient is already bleeding, so that any bleeding produced by the procedure would not be noticed.
It is important that the correct technique be used. Most gynecologists believe that: (1) A careful history and physical examination, including bimanual examination, should be done.
(2) A tenaculum should be placed on the cervix and a sound introduced into the uterus to determine its size and position. (3) The immediate post-partum period from three days until five or six weeks is not an optimal time for the introduction of an IUD. In many instances the uterus has still not involuted completely, and for an indefinite time it is so soft that the danger of perforation is great.
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Prior to the use of any IUDs (including the bow) in association with the immediate postpartum period practically no perforations were reported.
Because of the introducer, the bow lent itself particularly to perforation, especially if a tenaculum was not put on the cervix and a sound into the uterus. The force of the introduction would be more than enough to perforate a uterus if its actual position was not properly identified.
Perforations can occur not only with the bow, but with any IUD at this particular time (immediate post-partum three days to five or six weeks) and subsequent events have amply illustrated the truth of this statement. Numerous perforations are occurring in any country in which intrauterine devices are being used on a large scale.
The two perforations which Mr Mills reported in his series were both in pregnant women. Undoubtedly these would not have occurred if the diagnosis of pregnancy had been made prior to insertion.
The best time for insertion of a device is either immediately post-partum after the delivery of the placenta or during the third menstrual period after the baby is born.
X-ray examination can detect not only perforations by the bow but also by any IUD, even those with tails: the presence of a tail indicates only that the tail is in the cervix; it does not indicate that the top of the device has not perforated the uterine wall. Case reports throughout the literature have indicated that such perforations are occurring.
The expulsion rate with the immediate postpartum introduction of the bow is somewhere between 5 % and 10 %, depending on who does it. This is in marked contrast to the enormously high expulsion rate of either the spiral or the loop. Use rate of the bow has remained about 90% after two years, as compared with around 50% for the spiral or loop.
Because of our hysterosalpingography studies, the following conclusions have been reached:
(1) The intrauterine device must not only have a certain size but also a certain thickness. (2) The device must occupy about 85 % of the fundus.
Tailed devices were originally used to permit the patient to detect whether or not the device was expelled; for this reason a tail was put on the bow.
The occasional menorrhagia or spotting which occurs with an intrauterine device is, in all probability, due-to temporary follicle cystosis. The administration of ascorbic acid and an antihistaminic should overcome the difficulty in most cases. Because of the effect of an IUD in producing follicle cystosis and growth of the uterus, it is now being used to treat amenorrhoea in association with hypoplasia of the uterus and cervix. This has been experimentally confirmed by Dr Sheldon Segal on rats indicating that the IUDs cause a growth of the uterus.
Spontaneous perforation with the bow is very unlikely; there is definite evidence that the presence of a large bow in a small uterus will cause the lower half of the triangle to fold into such a shape as to accommodate itself to the uterus. Perforation with the bow in all probability occurred at the time of insertion.
All users of IUDs should have a thorough examination, including Papanicolaou smears, every six months.
Mr Wilfrid Mills, in reply to Mr Elstein, admitted that an increase in cervical mucus might occur with any IUD that included a tail or stalk but he could not accept the assumption that this was associated with endometritis or salpingitis. Any increascd incidence of salpingitis (which he personally had not seen) might be due to the discarding of the condom by the male consorts of thrse women.
In reply to Dr Birnberg, Mr Mills emphasized that no perforation had occurred due to insertion during pregnancy nor within three months of confinement. Pregnancy had followed the perforations as these patients were not protected. He could not agree that menorrhagia and irregular bleeding following the insertion of IUDs was due to ovarian dysfunction. Subsequent curetting of these patients showed endometrial morphology in accordance with the date of cycle but in some cases there seemed to be demonstrable cedema of the endometrium.
Dr Peter Eckstein, in reply to Mr Linton Snaith, said it was of course not impossible that IUDs could act as mechanical traps for spermatozoa, but he did not think it very likely. It would be very difficult to demonstrate such an action.
Although plastic materials were known to be biologically not entirely inert, it had not yet been shown that they attracted sperm. In fact, several deliberate endeavours to find sperm attached to the devices in experimental animals had failed.
